Searched for
LICENSING AGREEMENT IN PHARMA
Uzbekistan can provide more incentives to Indian pharma firms, aims to become regional hub for supplyUzbekistan is inviting Indian drug companies to invest more. They are offering better subsidies and technology help. This aims to make Uzbe...- Stocks in news: ITC, LIC, Sun Pharma, Maruti Suzuki, Fino Payments BankBenchmark indices experienced a negative close on Thursday, marked by volatile trade and profit booking. Analysts anticipate the Nifty to c...
- Profit on paper, loss in reality: How a routine accounting tool is used to deceive and take investors for a rideAmortisation is a number most investors skip, but it can shape reported profit. On the surface, it looks routine: A company spreads the cos...
- Sun Pharma shares rally 9% in two days after $12-bn Organon deal. Here's what Morgan Stanley, other brokerages saySun Pharmaceutical Industries' shares surged nearly 9% after announcing the $11.75 billion acquisition of Organon & Co., a global leader in...
- Zydus, Torrent Pharma join hands to co-market Semaglutide injectionZydus Lifesciences and Torrent Pharmaceuticals have joined forces to bring a new diabetes and weight management medication to India. Zydus ...
- Aurobindo joins hands with global pharma player to develop respiratory productsAurobindo Pharma's US subsidiary has partnered with a global pharmaceutical company to develop and sell respiratory products. The collabora...
- Mankind Pharma in licensing pact with Takeda to market acidity drug Vonoprazan in IndiaMankind Pharma partners with Takeda to introduce Vonoprazan for GERD, oesophagitis, ulcers, and Helicobacter pylori in India. EVP Ramesh st...
- Sun Pharma subsidiary partners with Aclaris Therapeutics for licensing agreementAs per the pact, Aclaris grants Sun Pharma exclusive rights to specific patents for using deuruxolitinib, Sun Pharma's JAK inhibitor, or ot...
- Aurobindo Pharma arm signs pact with Medicines Patent Pool to develop anti-cancer drugIndia's Aurobindo Pharma has announced that its subsidiary Eugia Pharma Specialities has signed a voluntary sub-licensing agreement with Me...
- Sun Pharma inks licensing pact with SPARC to commercialise medication in US marketSPARC submitted a new drug application (NDA) to the US Food and Drug Administration (US FDA) for the said product in February 2022.
- Torrent & Aurobindo receive licenses to sell Pfizer's COVID pill Paxlovid in India, low income countriesThe oral COVID-19 treatment comprises of nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating and ritonavir...
- Glenmark Pharma inks exclusive licensing agreement with Lotus InternationalGlenmark will receive an upfront payment as well as regulatory and sales-based milestone payments from Lotus, it added.
- Sun Pharma, Hikma ink exclusive pact for plaque psoriasis drug for MENA regionUnder the terms of the licensing agreement, Hikma will be responsible for the registration and commercialisation of the product in all MENA...
- Aurobindo Pharma, promoters settle insider trading case with SebiSebi had done an investigation into the trading in the scrip of Aurobindo Pharma during the period from July 22, 2008 to March 20, 2009
- Sun Pharma, US-based Rockwell Medical enter into licensing pact for Triferic in IndiaAs per the terms of the agreement, Sun Pharma will be the exclusive development and commercialisation partner for Triferic during the term ...
- Sun Pharma rises after licensing deal with AlmirallAt 11:01 am, shares of the company were trading at Rs 817.80 per share, up 1.24 per cent from its previous close on the Bombay Stock Exchan...
- SPARC, Sun Pharma climb on licensing agreementThe deal will make the company eligible for certain additional milestone payments and defined royalties linked to any future sales of ELEPS...
- Pharma sector gains from Re appreciationThe appreciation of the rupee might have brought in its share of woes for exporters and traders alike, but for the pharmaceutical sector wi...
- Elder Pharma, Israel co enter in-licensing dealMumbai-based Elder Pharmaceuticals has signed an exclusive in-licensing agreement with Israeli biotech company Enzymotec for the marketing ...
- Claris Lifesciences makes inroads into GermanyClaris Lifesciences, which recently attracted investment from leading international pharma group Carlyle, has formally made inroads into th...
Load More
